Healthcare Finance News September 25, 2018
Beth Jones Sanborn

While a majority of patients say they would consider the technologies to diagnose cancer and recommend treatment, they still fear costs.

WHAT HAPPENED

A new survey from McKesson and Ipsos revealed widespread openness toward AI and genetic testing as a solution for cancer diagnosis, but concern about cost is pervasive and could actually steer patients away from any treatment at all.

WHY IT MATTERS

According to information from the World Health Organization cited by McKesson, it is predicted that nearly 10 million people will die of cancer this year and more than 18 million new cases will be diagnosed around the world. Of the 2,012 adults Ipsos surveyed, 62 percent expressed concern about whether they could afford cancer treatment...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Patient / Consumer, Physician, Pricing / Spending, Provider, Technology
Amazon invests another $2.75B in Anthropic — reportedly ‘largest’ in company history
Policy at global conference focuses on three central issues
How Remote Patient Monitoring and AI Personalize Care
How Nebraska Medicine used AI to reduce first-year nurse turnover by nearly 50%
Social Isolation Linked to Being Older Than Biological Age, Greater Mortality

Share This Article